| Subjects | Group 1 | Group 2 |
| Type of analysis | Cell count and viability | Immunophenotyping |
| Subjects (n) | 48* | 29* |
| Samples |
|
|
| Control |
|
|
| Unstabilised (n) | Day 0 (48) | Day 0 (29) |
| Experimental |
|
|
| Unstabilised (n) | Day 2 (3) | Day 2 (3) |
|
| Day 4 (3) | Day 4 (3) |
|
| Day 6 (3) | Day 6 (3) |
|
| Day 8 (3) | Day 8 (3) |
|
| Day 10 (3) | Day 10 (3) |
| Experimental |
|
|
| Stabilisd (n) | Day 0 (3) | Day 0 (3) |
|
| Day 1 (9) | Day 1 (3) |
|
| Day 2 (8) | Day 2 (5) |
|
| Day 3 (4) | n/a |
|
| Day 4 (8) | n/a |
|
| Day 5 (18) | Day 5 (3) |
|
| Day 6 (5) | Day 6 (3) |
|
| Day 7 (25) | Day 7 (8) |
|
| Day 8 (6) | n/a |
|
| Day 9 (8) | Day 9 (4) |